David is the CEO of Maya, a psychedelic therapy intelligence platform designed to bring greater trust, transparency, and measurement to the participant journey. The platform is geared to become the world's largest database of psychedelic health outcomes, fueling insights to help psychedelic healthcare scale safely. David also directs Unlimited Sciences, a psychedelic research nonprofit combining academia with data science to understand underground psychedelic practices and surface best practices to inform further research. In 2019, he served as a campaign-lead in the Denver Psilocybin Initiative, helping Denver become the first US city to reform psilocybin policy. Prior, David was Co-founder & CPO at Baker Technologies, which he exited after achieving a valuation of $250MM.